Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Dover Corporation Q2 2026 Earnings Call - Raised EPS Guidance on 12% Growth and Data Center Liquid Cooling Surge
Dover delivered a quarter that reinforces the durability of its secular growth thesis. All-in revenue climbed 7%, with organic growth led by data center liquid cooling, aerospace, and clean energy, wh...
- Dover raised full-year adjusted EPS guidance, projecting double-digit growth after reporting 12% year-over-year EPS growth to $2.74 per share in Q2.
- All-in revenue grew 7% with 5% organic growth, driven by secular tailwinds in data center liquid cooling, aerospace, and clean energy that now represent 25% of the portfolio.
- Bookings momentum remains exceptional with orders up 16% year-over-year and a book-to-bill ratio of 1.06, providing rare breadth across all five segments.
- +9 more takeaways
MarineMax Q3 Fiscal 2026 Earnings Call - Margins Surge as Service Mix and Inventory Discipline Offset Soft Boat Sales
MarineMax reported a quarter where top-line pressure met bottom-line resilience. Revenue fell to $611 million and same-store sales dropped 7 percent, mirroring a retail environment still bruised by ma...
- Revenue declined to $611 million as same-store sales fell 7 percent, though the drop trailed broader industry unit volume declines.
- Gross margins expanded 530 basis points to 35.7 percent, driven by a strategic shift toward high-margin service, parts, finance and insurance, and marina operations.
- Underlying boat margins improved roughly 175 to 200 basis points year-over-year as dealer inventory normalizes, though they remain 300 to 400 basis points below pre-pandemic averages.
- +8 more takeaways
"Union Pacific" Q2 2026 Earnings Call - Record Financials and Raised EPS Guidance Fueled by Volume Growth and Operational Discipline
Union Pacific did not just meet expectations in the second quarter of 2026. It rewrote them. Operating revenue surged 12 percent to $6.9 billion while adjusted earnings per share climbed to $3.41, a p...
- Union Pacific delivered record Q2 2026 financials with $6.9 billion in operating revenue, a 12% year-over-year increase, driven by 2% volume growth and strong pricing.
- Adjusted earnings per share reached $3.41, while the operating ratio improved 10 basis points to 59.2%, with a core operating ratio of 58.0% excluding fuel volatility.
- Management raised full-year 2026 reported EPS growth guidance to the high single-digit range, citing stronger-than-expected volume momentum and disciplined cost management.
- +8 more takeaways
"Harley-Davidson" Q2 2026 Earnings Call - Guidance Raised as Dealer Health Improves and New Models Gain Traction
Harley-Davidson is finally turning the corner on its most critical vulnerability: dealer health. After seven consecutive quarters of inventory digestion, the company now reports that 85 percent of Nor...
- North American retail sales grew 3% in Q2, marking the third consecutive quarter of growth and reinforcing Harley’s 32% share of the US 601cc+ market.
- Dealer inventory health reached multi-year highs, with 85% of North American stock now representing model year 2026 units, down 15% year-over-year.
- Management raised full-year HDMC operating income guidance to $10 million to $50 million, flipping expectations from a potential loss to profitability.
- +7 more takeaways
Live Oak Bancshares Q2 2026 Earnings Call - Revenue Outpaces Costs as Checking and AI Initiatives Scale
Live Oak Bancshares delivered another quarter of compounding earnings power, with adjusted EPS rising 20% to $0.77 as core revenue expanded 11% while expenses contracted 1%. The bank’s operating lever...
- Adjusted EPS reached $0.77, up 20% year-over-year, driven by revenue growing 11% while total expenses contracted 1%.
- Loan production hit $1.5 billion across 33 industries, pushing the total loan book to $13 billion with a record $4.6 billion pipeline.
- Live Oak Express posted record $82 million in originations and $5 million in gains on sale, targeting a $750 million annual run rate.
- +7 more takeaways
Brandywine Realty Trust Q2 2026 Earnings Call - Raised $305M Sales Target; Philadelphia Leasing Outpaces Market Amid Austin Drag
Brandywine Realty Trust reported Q2 FFO of $0.13 per share, missing consensus by a penny but beating prior management guidance, while holding a full-year midpoint of $0.55. The dominant theme is capit...
- Q2 FFO came in at $0.13 per share. This misses consensus by a penny but beats the guidance management provided on the Q1 call. The full-year midpoint remains $0.55, with the range narrowed to reflect better-than-expected tenant retention and leasing activity.
- Management raised the asset sale target to $305 million, up $15 million from the original business plan. $208 million is already complete, and the remainder is under agreement with hard money deposits scheduled to close in Q3. Pricing across all sales is in line with original guidance.
- Leasing momentum is turning a corner. The company reported 88,000 square feet of positive net absorption in Q2. The operating portfolio pipeline grew 13% quarter-over-quarter to nearly 2 million square feet, with 456,000 square feet in advanced stages of negotiation. Management expects positive full-year net absorption for the first time in several years.
- +9 more takeaways
"Medpace" Q2 2026 Earnings Call - Backlog Conversion Runs Hot as Oncology Reclaims Mix and Cancellations Cool
Medpace delivered a quarter defined by operational tightening and a quiet structural shift. Revenue climbed 17.2 percent to $707.3 million, while net income surged 34.5 percent to $121.4 million, prov...
- Revenue and earnings are running hot. Q2 revenue hit $707.3 million, up 17.2 percent year over year, while net income surged 34.5 percent to $121.4 million, powered by operating leverage and a compressed effective tax rate.
- Backlog conversion is outpacing history. The burn rate climbed to 24.1 percent against a long term baseline near 18 percent. Management explicitly rejects the metabolic mix theory, pointing instead to stricter backlog gating and tighter interim analysis checkpoints.
- Oncology is reclaiming the throne. Therapeutic mix is shifting back to historical norms, with oncology now driving over half of new awards and bookings. The metabolic supercycle that concentrated revenue among the top five clients is cooling.
- +7 more takeaways
"Colony Bankcorp" Q2 2024 Earnings Call - Hits 1.20% Operating ROA While Prioritizing Pricing Discipline Over Volume
Colony Bankcorp finally cracked the code on its profitability mandate, delivering a 1.20% operating return on assets for the first time. The result came from a deliberate pivot: management chose prici...
- Colony Bankcorp finally hit its 1.20% operating ROA target, proving that disciplined pricing beats volume chasing in a volatile rate environment.
- Net interest margin expanded to 3.52%, driven by a six basis point jump in earning asset yields while funding costs held steady at 1.95%.
- Management chose pricing over pace. New and renewed loan rates stayed in the low sevens, pushing annualized growth to 8.5% but signaling near-term volume could slip below the 8% threshold.
- +7 more takeaways
"argenx" Q2 2026 Earnings Call - VYVGART Sales Hit $1.5B as Seronegative Expansion and Pipeline Catalysts Accelerate
argenx delivered another quarter of compounding execution, pushing VYVGART product net sales to $1.5 billion and securing its 18th consecutive quarter of growth. The commercial engine is clearly firin...
- Q2 2026 product net sales reached $1.5 billion, marking 60% year-over-year growth and the company’s 18th straight quarter of revenue expansion.
- U.S. commercial momentum is accelerating, with the prefilled syringe driving 80% new patient uptake in the quarter and expanding the prescriber base beyond 5,000 neurologists.
- The seronegative gMG label expansion added roughly 11,000 patients to the addressable market, with payers covering 55% of U.S. commercial lives in just ten weeks and largely eliminating mandatory serology testing.
- +7 more takeaways
"Rollins, Inc." Q2 2026 Earnings Call - Residential Demand Slowdown Triggers Revised Full-Year Guidance and Leadership Overhaul
Rollins delivered a solid topline but stumbled on execution where the market pays attention. Q2 revenue climbed 7.9 percent, yet organic growth of just 5.7 percent missed management targets. The weakn...
- Q2 revenue grew 7.9 percent year-over-year, but organic growth of 5.7 percent fell short of internal targets, driven by a concentrated slowdown in consumer-initiated residential demand.
- The weakness was highly channel-dependent. Digital and search-heavy brands like Orkin lagged, while relationship-driven names such as HomeTeam and Fox delivered double-digit organic growth.
- Customer retention remained stable and pricing power held firm, confirming the miss was purely a top-of-funnel volume issue rather than a deterioration in the customer base.
- +9 more takeaways